Michael Gough

Citat de

	Toate	Din 2020
Referințe bibliografice	6889	3208
h-index	46	30
i10-index	86	68

680

340

170

510

2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202545 69 97 136 144 196 203 204 195 147 155 164 149 173 141 176 234 270 363 366 550 663 604 656 628 105

Acces public

Afișați-le pe toate

49 de articole

4 articole

disponibile

indisponibile

Pe baza cerințelor privind finanțarea

Coautori

Pippa Newell, MDHepatobiliary and Pancreas Surgeon, The Oregon Clinic; Medical Director, Liver Cancer ProgramAdresă de e-mail confirmată pe providence.org
Bernard A. FoxHarder Family Chair for Cancer Research, Member and Chief, Molecular & Tumor Immunology, Earle AAdresă de e-mail confirmată pe providence.org
Keith BahjatSanofiAdresă de e-mail confirmată pe sanofi.com
Rom LeidnerEACRI Providence Portland, Oregon, USAAdresă de e-mail confirmată pe providence.org
William L. RedmondMember (Full Professor), Earle A. Chiles Research Institute, Providence Cancer InstituteAdresă de e-mail confirmată pe providence.org
Andrew GundersonAssistant Professor, The Ohio State UniversityAdresă de e-mail confirmată pe osumc.edu
Walter UrbaEarle A Chiles Research InstituteAdresă de e-mail confirmată pe providence.org
Atique U. Ahmed, Ph.D.Professor, Northwestern UniversityAdresă de e-mail confirmată pe northwestern.edu
Terry R. MedlerAssistant Member, Earle A. Chiles Research InstituteAdresă de e-mail confirmată pe providence.org
Brian D PieningEarle A Chiles Research InstituteAdresă de e-mail confirmată pe providence.org
carlo bifulcoCMO, Providence GenomicsAdresă de e-mail confirmată pe providence.org
Andrew M JacksonNottingham University, Duke University, Leeds University, Edinburgh University, Kennedy InstituteAdresă de e-mail confirmată pe nottingham.ac.uk
Garth TormoenRadiation Oncology at St. Mary’s Regional Medical CenterAdresă de e-mail confirmată pe primehealthcare.com
Rosamonde BanksUniversity of LeedsAdresă de e-mail confirmată pe leeds.ac.uk
Stephen TodrykProfessor of Immunology, Northumbria UniversityAdresă de e-mail confirmată pe northumbria.ac.uk
Ephraim TangAssistant Professor, University of Western OntarioAdresă de e-mail confirmată pe lhsc.on.ca
Kenneth OlivierMayo ClinicAdresă de e-mail confirmată pe mayo.edu
Luis Sanchez-PerezTune TherapeuticsAdresă de e-mail confirmată pe duke.edu
Thomas W. Dubensky, Jr.Tempest TherapeuticsAdresă de e-mail confirmată pe tempesttx.com
bonnotte bernardINSERM U1098Adresă de e-mail confirmată pe chu-dijon.fr

Urmăriți

Michael Gough

Earle A. Chiles Research Institute, Providence Cancer Center, Portland OR

Adresă de e-mail confirmată pe providence.org

Immunology cancer gene therapy


Titlu Sortați după descrierea bibliografică Sortați după an Sortați după titlu	Citat de Citat de	Anul
The potential use of laser capture microdissection to selectively obtain distinct populations of cells for proteomic analysis—preliminary findings RE Banks, MJ Dunn, MA Forbes, A Stanley, D Pappin, T Naven, M Gough, ... ELECTROPHORESIS: An International Journal 20 (4‐5), 689-700, 1999	413	1999
Timing of PD-1 blockade is critical to effective combination immunotherapy with anti-OX40 DJ Messenheimer, SM Jensen, ME Afentoulis, KW Wegmann, Z Feng, ... Clinical Cancer Research 23 (20), 6165-6177, 2017	332	2017
Optimizing timing of immunotherapy improves control of tumors by hypofractionated radiation therapy KH Young, JR Baird, T Savage, B Cottam, D Friedman, S Bambina, ... PloS one 11 (6), e0157164, 2016	327	2016
PKC-δ is an apoptotic lamin kinase T Cross, G Griffiths, E Deacon, R Sallis, M Gough, D Watters, JM Lord Oncogene 19 (19), 2331-2337, 2000	284	2000
Radiotherapy combined with novel STING-targeting oligonucleotides results in regression of established tumors JR Baird, D Friedman, B Cottam, TW Dubensky Jr, DB Kanne, S Bambina, ... Cancer research 76 (1), 50-61, 2016	248	2016
OX40 agonist therapy enhances CD8 infiltration and decreases immune suppression in the tumor MJ Gough, CE Ruby, WL Redmond, B Dhungel, A Brown, AD Weinberg Cancer research 68 (13), 5206-5215, 2008	197	2008
Facets of heat shock protein 70 show immunotherapeutic potential SM Todryk, MJ Gough, AG Pockley Immunology 110 (1), 1-9, 2003	187	2003
Role of the immunosuppressive microenvironment in immunotherapy GW Tormoen, MR Crittenden, MJ Gough Advances in radiation oncology 3 (4), 520-526, 2018	182	2018
Signaling through OX40 enhances antitumor immunity SM Jensen, LD Maston, MJ Gough, CE Ruby, WL Redmond, M Crittenden, ... Seminars in oncology 37 (5), 524-532, 2010	179	2010
Apoptosis or necrosis for tumor immunotherapy: what's in a name? A Melcher, M Gough, S Todryk, R Vile Journal of molecular medicine 77, 824-833, 1999	175	1999
Adjuvant therapy with agonistic antibodies to CD134 (OX40) increases local control after surgical or radiation therapy of cancer in mice MJ Gough, MR Crittenden, MC Sarff, P Pang, SK Seung, JT Vetto, HM Hu, ... Journal of immunotherapy 33 (8), 798-809, 2010	171	2010
TGFβ suppresses CD8⁺ T cell expression of CXCR3 and tumor trafficking AJ Gunderson, T Yamazaki, K McCarty, N Fox, M Phillips, A Alice, T Blair, ... Nature communications 11 (1), 1749, 2020	161	2020
Viral fusogenic membrane glycoproteins kill solid tumor cells by nonapoptotic mechanisms that promote cross presentation of tumor antigens by dendritic cells AR Bateman, KJ Harrington, T Kottke, A Ahmed, AA Melcher, MJ Gough, ... Cancer research 62 (22), 6566-6578, 2002	155	2002
Macrophages orchestrate the immune response to tumor cell death MJ Gough, AA Melcher, A Ahmed, MR Crittenden, DS Riddle, ... Cancer Research 61 (19), 7240-7247, 2001	147	2001
A simple method to cure established tumors by inflammatory killing of normal cells GA Daniels, L Sanchez-Perez, RM Diaz, T Kottke, J Thompson, M Lai, ... Nature biotechnology 22 (9), 1125-1132, 2004	145	2004
Germinal center reactions in tertiary lymphoid structures associate with neoantigen burden, humoral immunity and long-term survivorship in pancreatic cancer AJ Gunderson, V Rajamanickam, C Bui, B Bernard, J Pucilowska, ... Oncoimmunology 10 (1), 1900635, 2021	129	2021
Neoadjuvant immunoradiotherapy results in high rate of complete pathological response and clinical to pathological downstaging in locally advanced head and neck squamous cell … R Leidner, M Crittenden, K Young, H Xiao, Y Wu, MA Couey, AA Patel, ... Journal for immunotherapy of cancer 9 (5), e002485, 2021	122	2021
Cells as vehicles for cancer gene therapy: the missing link between targeted vectors and systemic delivery? K Harrington, L Alvarez-Vallina, M Crittenden, M Gough, H Chong, ... Human gene therapy 13 (11), 1263-1280, 2002	120	2002
Expression of NF-κB p50 in tumor stroma limits the control of tumors by radiation therapy MR Crittenden, B Cottam, T Savage, C Nguyen, P Newell, MJ Gough PloS one 7 (6), e39295, 2012	118	2012
A hypofractionated radiation regimen avoids the lymphopenia associated with neoadjuvant chemoradiation therapy of borderline resectable and locally advanced pancreatic … T Crocenzi, B Cottam, P Newell, RF Wolf, PD Hansen, C Hammill, ... Journal for ImmunoTherapy of Cancer 4, 1-13, 2016	112	2016

Sistemul nu poate realiza operația în acest moment. Încercați din nou mai târziu.

Articole 1–20

Referințe bibliografice pe an

Citate duplicat

Citate fuzionate

Adăugați coautoriCoautori

Urmăriți

Citat de

Coautori